ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1471

Trends and Predictors of Hospitalizations Due to Acute Myocardial Infarction in Systemic Lupus Erythematosus Patients

Izza Bazigh1, Uzair Khan2, Achint Patel3, Aaparna Singh3, Neha Ghalib3, Ghazi Farman4, Salman Muddassir3, Farrukh Zaidi5, Sami Mughni3 and Adam Grunbaum6, 1HCA Florida Oak Hill Hospital, Spring Hill, FL, 2HCA Healthcare Florida / USF Morsani College of Medicine GME Consortium / Oak Hill Hospital, Odessa, FL, 3HCA Healthcare Florida / USF Morsani College of Medicine GME Consortium / Oak Hill Hospital, Spring Hill, FL, 4Rehman Medical College, Spring Hill, FL, 5HCA Healthcare Florida / USF Morsani College of Medicine GME Consortium / Oak Hill Hospital, Port Richey, FL, 6Gulf Coast Rheumatology, Trinity, FL

Meeting: ACR Convergence 2022

Keywords: Epidemiology, Heart disease, Myocardial Infarction, risk factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: SLE – Diagnosis, Manifestations, and Outcomes Poster II: Manifestations

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Cardiovascular events occur more frequently and with earlier onset in patients with Systemic Lupus Erythematosus (SLE) compared with healthy individuals. Several studies have concluded that alteration of the immune system and cytokine axis coupled with increase in oxidative stress accelerate plaque formation and destabilization. Moreover, anti-phospholipid was also found to promote thrombosis in SLE patients. Although several studies have linked SLE with increased risk of Acute Myocardial Infarction (AMI), recent epidemiological data from large population-based studies is lacking. In our study, we aimed to analyze temporal trends and predictors associated with increased risk of hospitalizations due to AMI among SLE patients by using nationally representative dataset from the United States.

Methods: We analyzed Nationwide Inpatient Sample (NIS) and Healthcare Cost and Utilization Project (HCUP) data for years 2010-2018. Hospitalizations among adult SLE patients were identified by previously validated ICD-9/10-CM codes. Proportion of hospitalizations due to primary diagnosis of AMI was calculated. We then utilized the Cochrane Armitage trend test and multivariate survey logistic regression models to analyze trends and predictors of AMI among SLE patients. We used SAS 9.4 software for analyzing the data.

Results: Out of a total of 1,636,848 hospitalizations among SLE patients, 22,424 (1.4%) were due to primary diagnosis of AMI. Temporal trend of hospitalization due to AMI among SLE patients increased from 1,864 (1.1%) in 2010 to 2,835 (1.6%) in 2018 (p:< 0.001) with annual increase of 4% (OR 1.04; 95%CI 1.02-1.06; p< 0.0001). Even after adjusting with changes in demographics and comorbidities, we observed a similar trend. In multivariable regression analysis, we found that increasing age (OR 1.05; 95%CI 1.03-1.06; p< 0.0001), male gender (OR 1.35; 95%CI 1.34-1.38; p< 0.001), antiphospholipid antibodies (OR 1.17; 95%CI 1.01-1.37; p:0.045), smoking (OR 2.01; 95%CI 1.87-2.15; p< 0.0001) as well as comorbidities such as hypertension (OR 1.19; 95%CI 1.11-1.28; p< 0.0001), diabetes mellitus, chronic renal failure and obesity were associated with increased odds of hospitalization due to AMI among SLE patients. Overall, in-hospital mortality was higher during hospitalization due to AMI (4.6% vs 1.7%; p< 0.001) and the trend remained stable during the study period. Hospitalization due to AMI demonstrated mean length of stay of 5-days.

Conclusion: We observed a statistically significant increase in the trend of hospitalizations due to AMI among SLE patients from year 2010 to 2018. We identified several risk predictors such as demographics and comorbidities associated with higher odds of hospitalization due to AMI among SLE patients. Further in-depth studies are warranted to understand the causality of increased risk and formulate preventive strategies in the long run that would help mitigate the risk of AMI in SLE patients.

Supporting image 1

Temporal Trends of Hospitalizations due to Acute Myocardial Infarction among Systemic Lupus Erythmetosus Patients


Disclosures: I. Bazigh, None; U. Khan, None; A. Patel, None; A. Singh, None; N. Ghalib, None; G. Farman, None; S. Muddassir, None; F. Zaidi, None; S. Mughni, None; A. Grunbaum, None.

To cite this abstract in AMA style:

Bazigh I, Khan U, Patel A, Singh A, Ghalib N, Farman G, Muddassir S, Zaidi F, Mughni S, Grunbaum A. Trends and Predictors of Hospitalizations Due to Acute Myocardial Infarction in Systemic Lupus Erythematosus Patients [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/trends-and-predictors-of-hospitalizations-due-to-acute-myocardial-infarction-in-systemic-lupus-erythematosus-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trends-and-predictors-of-hospitalizations-due-to-acute-myocardial-infarction-in-systemic-lupus-erythematosus-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology